Kenya AIDS Vaccine Initiative Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2003
NCT01371175
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

KAVI (Kenya AIDS Vaccine Initiative) | Kenya AIDS Vaccine Initiative - Institute of Clinical Research (KAVI-ICR) | Kenya AIDS Vaccine Initiative, Kangemi, Kenya